Aura Biosciences (AURA) Accounts Payables (2020 - 2026)

Aura Biosciences' Accounts Payables history runs 7 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• Quarterly Accounts Payables rose 28.27% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 28.27% YoY) and the FY2025 annual result came in at $1.5 million, down 32.77% from the prior year.
• Accounts Payables was $2.6 million for Q1 2026 at Aura Biosciences, up from $1.5 million in the prior quarter.
• Across five years, Accounts Payables topped out at $2.9 million in Q4 2022 and bottomed at $553000.0 in Q2 2023.
• A 5-year average of $1.7 million and a median of $1.8 million in 2023 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2023 — Accounts Payables slumped 53.84% — and 2024, when it jumped 163.83%.
• Aura Biosciences' Accounts Payables stood at $2.9 million in 2022, then slumped by 38.82% to $1.8 million in 2023, then increased by 28.93% to $2.3 million in 2024, then tumbled by 32.77% to $1.5 million in 2025, then soared by 66.11% to $2.6 million in 2026.
• Business Quant data shows AURA's Accounts Payables at $2.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.9 million in Q3 2025.